• Activity INFORMATION

  Overview

  In a podcast style discussion, Mike Corvino, PharmD and Cole Swanson, PharmD examine rheumatoid arthritis management. They discuss the treatment options in detail including disease-modifying antirheumatic drugs (DMARDs) as well as biologic therapies. New medications used to treat rheumatoid arthritis have come to market in the last year and can be beneficial to certain patients.  Pharmacists and nurses regularly encounter patients with this condition and who take these medications. It is important that pharmacists and nurses understand the appropriate use of these medications and know how to identify side effects associated with them. This session seeks to explore these topics, focusing on how this information can best be incorporated into daily medical practice.

  Access the original podcast here.

  
  

  Handouts

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Recognize pertinent lab values related to the diagnosis and clinical severity of rheumatoid arthritis

  Identify pathophysiology, signs and symptoms, and risk factors for rheumatoid arthritis

  Recognize specific inflammatory targets and appropriate use of biologic therapies

  Review aspects of treatment with disease-modifying antirheumatic drugs (DMARDs)

  Identify side effects and risks associated with DMARDs

  Nurse

  Review aspects of treatment with disease-modifying antirheumatic drugs (DMARDs)

  Identify pathophysiology, signs and symptoms, and risk factors for rheumatoid arthritis

  Identify side effects and risks associated with DMARDs

  Recognize pertinent lab values related to the diagnosis and clinical severity of rheumatoid arthritis

  Recognize specific inflammatory targets and appropriate use of biologic therapies

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-919328

  Universal Activity Number

  Pharmacist 0798-0000-22-206-H01-P
  Nurse 0798-0000-22-206-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Coleman  Swanson, PharmD, CDCES Clinical Pharmacist - Neurology, MUSC Specialty Pharmacy Department

  Michael  Corvino, PharmD, BCPS, BCACP, CDCES Clinical Pharmacist, Fetter Health Care Network

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).